Cargando…
Tryptophan-Degrading Enzymes in Tumoral Immune Resistance
Tryptophan is required for T lymphocyte effector functions. Its degradation is one of the mechanisms selected by tumors to resist immune destruction. Two enzymes, tryptophan-2,3-dioxygenase and indoleamine 2,3-dioxygenase 1, control tryptophan degradation through the kynurenine pathway. A third prot...
Autores principales: | van Baren, Nicolas, Van den Eynde, Benoît J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315104/ https://www.ncbi.nlm.nih.gov/pubmed/25691885 http://dx.doi.org/10.3389/fimmu.2015.00034 |
Ejemplares similares
-
Expression profile of the human IDO1 protein, a cancer drug target involved in tumoral immune resistance
por: Vigneron, Nathalie, et al.
Publicado: (2015) -
Tryptophan 2,3-Dioxygenase Expression Identified in Murine Decidual Stromal Cells Is Not Essential for Feto-Maternal Tolerance
por: Hoffmann, Delia, et al.
Publicado: (2020) -
Systemic tryptophan homeostasis
por: Klaessens, Simon, et al.
Publicado: (2022) -
Editorial: Heme proteins: key players in the regulation of immune responses
por: Volpi, Claudia, et al.
Publicado: (2023) -
Tryptophan-Catabolizing Enzymes – Party of Three
por: Ball, Helen J., et al.
Publicado: (2014)